1. Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy
   Zilan Zhou et al, 2017, Mol. Pharmaceutics CrossRef
2. Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
   Yi‐Nan Liu et al, 2019, Int. J. Cancer CrossRef
3. null
   Yi Wen Kong et al, 2016 CrossRef
4. The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect
   Yingyu Dou et al, 2019, J Ovarian Res CrossRef
5. Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity.
   Shannon Lee et al, 2020, Int J Mol Sci CrossRef
6. Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel.
   Manabu Seino et al, 0 CrossRef
7. Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo
   Hiroyuki Takeda et al, 2017, Oncotarget CrossRef
8. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer
   Ji Hee Ha et al, 2016, Oncotarget CrossRef
9. Platinum-based combination therapy: molecular rationale, current clinical uses, and future perspectives
   Chunqiu Yu et al, 2020, J. Med. Chem. CrossRef
10. Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies
    Kathleen Wantoch von Rekowski et al, 2020, IJMS CrossRef
11. The role of endolysosomal trafficking in anticancer drug resistance
    Noor A. Hussein et al, 2021, Drug Resistance Updates CrossRef
12. Inhibition of c-Jun N-terminal kinase signaling promotes osteoblastic differentiation of periodontal ligament stem cells and induces regeneration of periodontal tissues
    Hiroshi Kaneko et al, 2021, Archives of Oral Biology CrossRef
13. Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma
    Lesley Jia Wei Pua et al, 2022, IJMS CrossRef
14. Circular RNA circ_0004488 Increases Cervical Cancer Paclitaxel Resistance via the miR-136/MEX3C Signaling Pathway
    Hanjie Yi et al, 2022, Journal of Oncology CrossRef
15. Hypoxia-induced paclitaxel resistance in cervical cancer modulated by miR-100 targeting of USP15
    Hirotaka Nishi et al, 2023, Gynecologic Oncology Reports CrossRef
16. Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer
    Yurou Chen et al, 2024, Nat Commun CrossRef